<p>Join our host, <a href="https://www.linkedin.com/in/larry-zeifman-1585212/">Larry Zeifman</a> and this week's guests, <a href="https://www.linkedin.com/in/henri-sant-cassia/">Henry Sant-Cassia</a>, Founding-Partner of The Conscious Fund and <a href="https://www.linkedin.com/in/patrickmoher/">Patrick Moher,</a> CEO of Microdose Psychedelic Insights as they discuss Canadian psychedelic companies raising funds, financing for new entrants and why psychedelic companies are sought out by investors.<br> <br> <a href="https://www.zeifmans.ca/">About Zeifmans</a></p> <p>Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit <a href="https://www.zeifmans.ca/industries/cannabis-psychedelics/" rel="ugc noopener noreferrer" target="_blank">zeifmans.ca.</a><br> <br> <a href="https://theconscious.fund/">About The Conscious Fund</a></p> <p>The Conscious Fund invests in global early-stage ventures in psychedelic medicine, helping deliver better outcomes for mental health, addiction, and pain.<br> <br> <a href="https://microdose.buzz/">About Microdose Psychedelic Insights</a>&nbsp;</p> <p>Microdose's vision is to distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry into the forefront of modern medicine.<br> </p>